Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

“Adaptive Licensing” Proposals View REMS As Answer To Limited Evidence

Mar 12 2012

• By Sue Sutter

Related Content

Accelerated Approval Could Expand As Alternative To Progressive Approval

Jan 23 2012

FDA Expanding Accelerated Approval Through Guidance, Collaboration

Mar 12 2012

FDA Exploring Limited-Use Approvals For Antibiotics Based On Small Development Programs

Mar 07 2012

Accelerated Approval Expansion Proposals Pending, But One Needs An Overhaul

Feb 06 2012

Expedited Approval Pathway Concept Draws Strong Support But Different Proposals

Dec 05 2011

FDA’s Jenkins On “Progressive Approval”: Don’t Lower The Efficacy Bar

Dec 19 2011

FDA Biomedical Innovation Initiative Draws On Familiar Themes

Oct 10 2011

REMS Templates Get Nod From FDA, With Nudge From Pharmacists

Jul 28 2010

Biologics Reached Record Share Of Novel Approvals In 2009

Jan 01 2010

Additional Topics

Clinical Trials Post Market Regulation & Studies Risk Management Drug Approval Standards BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window